News-Papers
Testimonial
Video Gallery
ID76-Article
ID96-Article
ID112-Article
ID139-Article
ID157-Article
ID181-Article
ID192-Article
ID209-Article
ID466-Article
ID468-Article
ID2083-Article
Powered by Phoca Gallery
Search
Follow us...
Latest
- Melatonin Overcomes Cancer Multidrug Resistance by Downregulating ABCB1 Expression and Modulating Mitochondrial Function
- Melatonin as an anti-inflammatory agent in radiotherapy
- The melatonin immunomodulatory actions in radiotherapy
- Radioprotective effect of endogenous melatonin secretion associated with the circadian rhythm in irradiated rats
- Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
- Clinical Applications of Melatonin in Radiotherapy: a Review
- Melatonin Modulation of Radiation and Chemotherapeutics-induced Changes on Differentiation of Breast Fibroblasts
- Modulating effects of famotidine and melatonin on high dose radiation induced cell lethality in normal human and cancer cell lines
- Impact of Cholecalciferol Supplementation on Radiotherapy Outcomes in Advanced Cervical Cancer
- Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis
- Modulation of Radiation-induced Base Excision Repair Pathway Gene Expression by Melatonin
- Radioprotective and Radiomitigative Effects of Melatonin in Tissues with Different Proliferative Activity
- Anti-apoptotic and antioxidant effects of melatonin protect spleen of whole body γ-irradiated male Sprague-dawley rats
- Melatonin can Ameliorate Radiation-Induced Oxidative Stress and Inflammation-Related Deterioration of Bone Quality in Rat Femur
- Amifostine and melatonin attenuate radiation-induced oxidative stress, inflammation, and fibrotic remodeling in the vocal folds and subglottic glands of rats
- Melatonin and Vitamins: A Promising Combination to Augment Conventional Anticancer Therapies
- Targeted radionuclide therapy for gliomas: Emerging clinical trial landscape
- Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Bibliography
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- How effective is chemo therapy?
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer